Form 4: BiomX Inc. Director Jesse Goodman Acquires 264,000 Stock Options
SEC Form 4 Filing
Director Jesse Goodman reports acquisition of 264,000 stock options in BiomX Inc.
Summary
- On July 11, 2024, Jesse Goodman, a director of BiomX Inc., acquired 264,000 common stock options.
- The exercise price of these options is $0.363.
- The options vest over four years, with 25% vesting on July 11, 2025, and the remainder vesting in 12 equal quarterly installments over three years.
- The options expire on July 11, 2034.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard reporting of stock option acquisition.
Industry Context
This is a standard disclosure related to insider transactions, common in the biopharmaceutical industry where stock options are frequently used as part of executive compensation packages.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of transaction: Jesse Goodman acquired 264,000 common stock options. |
| 07/11/2025 | 25% of the acquired stock options vest. |
| 07/11/2034 | Expiration date of the acquired stock options. |
| 07/15/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.